Background Nintedanib is an inhibitor targeting platelet-derived growth factor receptor, fibroblast growth factor receptor and vascular endothelial growth factor receptor tyrosine kinases that has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results